To include your compound in the COVID-19 Resource Center, submit it here.

CAR Ts Kymriah, Yescarta get green light in EU

The European Commission approved Kymriah tisagenlecleucel from Novartis AG (NYSE:NVS; SIX:NOVN) and Yescarta axicabtagene ciloleucel from the Kite Pharma Inc. subsidiary of Gilead Sciences Inc. (NASDAQ:GILD), making them the

Read the full 295 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE